Literature DB >> 12269971

Performance characteristics of scintigraphic transit measurements for studies of experimental therapies.

F Cremonini1, B P Mullan, M Camilleri, D D Burton, M R Rank.   

Abstract

BACKGROUND: The intra- and inter-individual reproducibility of gastrointestinal and colonic transit tests require full characterization. AIMS: (i) To characterize the normal values and reproducibility effects of age and gender on the scintigraphic transit of solids in health. (ii) To compare scintigraphic and radio-opaque marker measurements of colonic transit. (iii) To estimate demonstrable effect sizes for different transit end-points based on observed variations.
METHODS: A scintigraphic gastrointestinal and colonic transit study and the mean colonic transit time were measured using radio-opaque markers in 37 healthy volunteers; 21 subjects had a repeat scintigraphic test 3 weeks later.
RESULTS: Gastric emptying at 4 h was highly reproducible (coefficient of variation, 4%) on repeat testing. The colonic measurement varied by more than 1 geometric centre unit in 37% of subjects at 24 h and in 26% of subjects at 48 h. There were no age- or gender-related differences in transit. Effect sizes demonstrable with 14 subjects per group were in the range previously shown to be clinically relevant: 25% change in gastric emptying at 4 h; 1.5 geometric centre unit change in colonic transit at 48 h.
CONCLUSIONS: These data demonstrate the reproducibility and performance to be expected of transit measurements and are essential for designing studies in experimental therapeutics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12269971     DOI: 10.1046/j.1365-2036.2002.01344.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  78 in total

Review 1.  Treating irritable bowel syndrome: overview, perspective and future therapies.

Authors:  Michael Camilleri
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

Review 2.  Methods for the assessment of small-bowel and colonic transit.

Authors:  Lawrence A Szarka; Michael Camilleri
Journal:  Semin Nucl Med       Date:  2012-03       Impact factor: 4.446

3.  Anorectal disorders.

Authors:  Adil E Bharucha; Arnold M Wald
Journal:  Am J Gastroenterol       Date:  2010-04       Impact factor: 10.864

Review 4.  Measurement of gastrointestinal transit.

Authors:  Henry C Lin; Charlene Prather; Robert S Fisher; James H Meyer; Robert W Summers; Mark Pimentel; Richard W McCallum; Louis M A Akkermans; Vera Loening-Baucke
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

5.  HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome.

Authors:  Maria I Vazquez-Roque; Michael Camilleri; Paula Carlson; Sanna McKinzie; Joseph A Murray; Tricia L Brantner; Duane D Burton; Alan R Zinsmeister
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-06       Impact factor: 2.566

6.  Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis.

Authors:  M Camilleri; P Carlson; S McKinzie; M Zucchelli; M D'Amato; I Busciglio; D Burton; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2011-07-14       Impact factor: 3.598

7.  Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome.

Authors:  Johanna Iturrino; Michael Camilleri; Irene Busciglio; Duane Burton; Alan R Zinsmeister
Journal:  Dig Liver Dis       Date:  2013-10-04       Impact factor: 4.088

8.  Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Sanna McKinzie; Irene Busciglio; Phillip A Low; Seth Sweetser; Duane Burton; Kari Baxter; Michael Ryks; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

9.  Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity.

Authors:  Suwebatu T Odunsi; María I Vázquez-Roque; Michael Camilleri; Athanasios Papathanasopoulos; Matthew M Clark; Lynne Wodrich; Mary Lempke; Sanna McKinzie; Michael Ryks; Duane Burton; Alan R Zinsmeister
Journal:  Obesity (Silver Spring)       Date:  2009-12-03       Impact factor: 5.002

10.  Standard medical therapies do not alter colonic transit time in children with treatment-resistant slow-transit constipation.

Authors:  Melanie C C Clarke; Janet W Chase; Susie Gibb; Anthony G Catto-Smith; John M Hutson; Bridget R Southwell
Journal:  Pediatr Surg Int       Date:  2009-05-16       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.